NDC 57894-071 – Simponi
Golimumab 100 mg/mL · Injection, Solution · Subcutaneous
Product NDC57894-071
Product details
- Brand name
- Simponi
- Generic name
- golimumab
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA125289
- Marketed since
- May 15, 2013
- Listing expires
- December 31, 2027
- Pharmacologic class
- Tumor Necrosis Factor Blocker
Active ingredients
- Golimumab 100 mg/mL
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 57894-071-01 | 1 SYRINGE, GLASS in 1 CARTON (57894-071-01) / 1 mL in 1 SYRINGE, GLASS | May 15, 2013 |
| 57894-071-02 | 1 SYRINGE in 1 CARTON (57894-071-02) / 1 mL in 1 SYRINGE | May 15, 2013 |
| 57894-071-89 sample | 1 SYRINGE in 1 CARTON (57894-071-89) / 1 mL in 1 SYRINGE | May 15, 2013 |
| 57894-071-90 sample | 1 SYRINGE, GLASS in 1 CARTON (57894-071-90) / 1 mL in 1 SYRINGE, GLASS | May 15, 2013 |
Other Simponi products
- 57894-070 Golimumab 50 mg/.5mL · Injection, Solution · Janssen Biotech, Inc.